13:03 IST
NSE
Regulatory ApprovalAurobindo Pharma Ltd AUROPHARMA
Aurobindo Pharma Regulatory Approval
Aurobindo Pharma received USFDA final approval for its first MDI product, Beclomethasone Dipropionate HFA Inhalation Aerosol. The US market for this segment is estimated at US$301 million.